FluoGuide A/S
FLUO
Rank in Stocks
#22801
FluoGuide A/S is a Danish life science company dedicated to developing and... FluoGuide A/S is a Danish life science company dedicated to developing and commercializing advanced surgical solutions. Its flagship investigational compound, FG001, is currently undergoing Phase I/II clinical trials for the treatment of high-grade glioma (a type of brain cancer) and has also advanced to Phase II development for lung cancer. The company is further developing FG002, a preclinical-stage product that utilizes novel uPAR-targeted luminescent technology to enable surgeons to distinguish cancerous from healthy tissue during operations. FluoGuide A/S has established key collaborations, including an agreement with Linköping University Hospital to support the Phase I/II clinical evaluation of FG001 for the surgical removal of brain tumors, and an ongoing partnership with Copenhagen University Hospital. The company was founded in 2018 and maintains its headquarters in Copenhagen, Denmark.
Share Price
$3.03
Last synced: 2026-11-09
Market Cap
$49.54M
Change (1 day)
-1.40%
Change (1 year)
-37.69%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade FluoGuide A/S (FLUO)
Category
Healthcare
EPS for FluoGuide A/S (FLUO)
EPS as of June 2026 TTM: $-0.45
According to FluoGuide A/S's latest financial reports, its current EPS (TTM) is $-0.45. At the end of 2025 the company had an EPS of $-0.45, a decrease compared to its 2024 EPS of $-0.31.
EPS history for FluoGuide A/S from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.45 | -0.53% |
| 2025 | $-0.45 | 44.91% |
| 2024 | $-0.31 | -34.75% |
| 2023 | $-0.48 | 42.16% |
| 2022 | $-0.34 | 2.01% |
| 2021 | $-0.33 | 12.53% |
| 2020 | $-0.29 | 30.68% |
| 2019 | $-0.22 | 1,606.87% |
| 2018 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -3,598.66% |
US
|
|
| $-7.07 | 1,479.54% |
US
|
|
| $-5.29 | 1,081.86% |
AU
|
|
| $12.88 | -2,977.59% |
BE
|
|
| $21.56 | -4,916.80% |
NL
|
Questions about FluoGuide A/S's earnings per share (EPS)
What is FluoGuide A/S's earnings per share (EPS)?
FluoGuide A/S's earnings per share (EPS) over the last twelve months is $-0.45, as of Jun 2026.
What was FluoGuide A/S's earnings per share (EPS) in 2025?
In 2025, FluoGuide A/S's earnings per share (EPS) was $-0.45, compared with $-0.31 in 2024.
How has FluoGuide A/S's earnings per share (EPS) changed since 2020?
From 2020 to 2025, FluoGuide A/S's earnings per share (EPS) was highest in 2020 ($-0.29) and lowest in 2023 ($-0.48).
How does FluoGuide A/S's earnings per share (EPS) compare with similar companies?
FluoGuide A/S's earnings per share (EPS) ($-0.45) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.